MENU
XFOR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

X4 Pharmaceuticals (XFOR) Earnings Date & Reports

X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

XFOR is expected to report earnings to rise 43.08% to -18 cents per share on October 29

X4 Pharmaceuticals XFOR Stock Earnings Reports
Q3'26
Est.
$-0.19
Q2'26
Beat
by $0.06
Q1'26
Missed
by $0.04
Q4'25
Missed
by $0.11
Q3'25
Missed
by $0.56
The last earnings report on August 06 showed earnings per share of -12 cents, beating the estimate of -18 cents. With 956.07K shares outstanding, the current market capitalization sits at 400.55M.
View a ticker or compare two or three
XFOR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a biotechnology company which engages in developing human antibodies for treating infectious diseases

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
61 North Beacon Street
Phone
+1 857 529-8300
Employees
93
Web
https://www.x4pharma.com